GPCR-agonister
Forbindelser med formel (I): (I) eller farmasøytisk akseptable salter derav, er GPCR-agonister og er anvendelige når det gjelder behandlingen av fedme og diabetes. Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | nor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RASAMISON CHRYSTELLE MARIE JEEVARATNAM REVATHY PERPETUA WILLIAMS GEOFFREY MARTYN SWAIN SIMON ANDREW SMITH COLIN PETER SAMBROOK RUSHWORTH PHILIP JOHN FYFE MATTHEW COLIN THOR BRADLEY STUART EDWARD KEILY JOHN PROCTER MARTIN JAMES STONEHOUSE DAVID FRENCH BERTRAM LISA SARAH GATTRELL WILLIAM |
| description | Forbindelser med formel (I): (I) eller farmasøytisk akseptable salter derav, er GPCR-agonister og er anvendelige når det gjelder behandlingen av fedme og diabetes.
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NO20080010LL</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NO20080010LL</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NO20080010LL3</originalsourceid><addsrcrecordid>eNrjZOBzD3AO0k1Mz8_LLC5JLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfF-_kYGBhYGBoYGPj7GxKgBADoJHlY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GPCR-agonister</title><source>esp@cenet</source><creator>RASAMISON CHRYSTELLE MARIE ; JEEVARATNAM REVATHY PERPETUA ; WILLIAMS GEOFFREY MARTYN ; SWAIN SIMON ANDREW ; SMITH COLIN PETER SAMBROOK ; RUSHWORTH PHILIP JOHN ; FYFE MATTHEW COLIN THOR ; BRADLEY STUART EDWARD ; KEILY JOHN ; PROCTER MARTIN JAMES ; STONEHOUSE DAVID FRENCH ; BERTRAM LISA SARAH ; GATTRELL WILLIAM</creator><creatorcontrib>RASAMISON CHRYSTELLE MARIE ; JEEVARATNAM REVATHY PERPETUA ; WILLIAMS GEOFFREY MARTYN ; SWAIN SIMON ANDREW ; SMITH COLIN PETER SAMBROOK ; RUSHWORTH PHILIP JOHN ; FYFE MATTHEW COLIN THOR ; BRADLEY STUART EDWARD ; KEILY JOHN ; PROCTER MARTIN JAMES ; STONEHOUSE DAVID FRENCH ; BERTRAM LISA SARAH ; GATTRELL WILLIAM</creatorcontrib><description>Forbindelser med formel (I): (I) eller farmasøytisk akseptable salter derav, er GPCR-agonister og er anvendelige når det gjelder behandlingen av fedme og diabetes.
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.</description><language>nor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080130&DB=EPODOC&CC=NO&NR=20080010L$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080130&DB=EPODOC&CC=NO&NR=20080010L$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RASAMISON CHRYSTELLE MARIE</creatorcontrib><creatorcontrib>JEEVARATNAM REVATHY PERPETUA</creatorcontrib><creatorcontrib>WILLIAMS GEOFFREY MARTYN</creatorcontrib><creatorcontrib>SWAIN SIMON ANDREW</creatorcontrib><creatorcontrib>SMITH COLIN PETER SAMBROOK</creatorcontrib><creatorcontrib>RUSHWORTH PHILIP JOHN</creatorcontrib><creatorcontrib>FYFE MATTHEW COLIN THOR</creatorcontrib><creatorcontrib>BRADLEY STUART EDWARD</creatorcontrib><creatorcontrib>KEILY JOHN</creatorcontrib><creatorcontrib>PROCTER MARTIN JAMES</creatorcontrib><creatorcontrib>STONEHOUSE DAVID FRENCH</creatorcontrib><creatorcontrib>BERTRAM LISA SARAH</creatorcontrib><creatorcontrib>GATTRELL WILLIAM</creatorcontrib><title>GPCR-agonister</title><description>Forbindelser med formel (I): (I) eller farmasøytisk akseptable salter derav, er GPCR-agonister og er anvendelige når det gjelder behandlingen av fedme og diabetes.
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOBzD3AO0k1Mz8_LLC5JLeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfF-_kYGBhYGBoYGPj7GxKgBADoJHlY</recordid><startdate>20080130</startdate><enddate>20080130</enddate><creator>RASAMISON CHRYSTELLE MARIE</creator><creator>JEEVARATNAM REVATHY PERPETUA</creator><creator>WILLIAMS GEOFFREY MARTYN</creator><creator>SWAIN SIMON ANDREW</creator><creator>SMITH COLIN PETER SAMBROOK</creator><creator>RUSHWORTH PHILIP JOHN</creator><creator>FYFE MATTHEW COLIN THOR</creator><creator>BRADLEY STUART EDWARD</creator><creator>KEILY JOHN</creator><creator>PROCTER MARTIN JAMES</creator><creator>STONEHOUSE DAVID FRENCH</creator><creator>BERTRAM LISA SARAH</creator><creator>GATTRELL WILLIAM</creator><scope>EVB</scope></search><sort><creationdate>20080130</creationdate><title>GPCR-agonister</title><author>RASAMISON CHRYSTELLE MARIE ; JEEVARATNAM REVATHY PERPETUA ; WILLIAMS GEOFFREY MARTYN ; SWAIN SIMON ANDREW ; SMITH COLIN PETER SAMBROOK ; RUSHWORTH PHILIP JOHN ; FYFE MATTHEW COLIN THOR ; BRADLEY STUART EDWARD ; KEILY JOHN ; PROCTER MARTIN JAMES ; STONEHOUSE DAVID FRENCH ; BERTRAM LISA SARAH ; GATTRELL WILLIAM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NO20080010LL3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>nor</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>RASAMISON CHRYSTELLE MARIE</creatorcontrib><creatorcontrib>JEEVARATNAM REVATHY PERPETUA</creatorcontrib><creatorcontrib>WILLIAMS GEOFFREY MARTYN</creatorcontrib><creatorcontrib>SWAIN SIMON ANDREW</creatorcontrib><creatorcontrib>SMITH COLIN PETER SAMBROOK</creatorcontrib><creatorcontrib>RUSHWORTH PHILIP JOHN</creatorcontrib><creatorcontrib>FYFE MATTHEW COLIN THOR</creatorcontrib><creatorcontrib>BRADLEY STUART EDWARD</creatorcontrib><creatorcontrib>KEILY JOHN</creatorcontrib><creatorcontrib>PROCTER MARTIN JAMES</creatorcontrib><creatorcontrib>STONEHOUSE DAVID FRENCH</creatorcontrib><creatorcontrib>BERTRAM LISA SARAH</creatorcontrib><creatorcontrib>GATTRELL WILLIAM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RASAMISON CHRYSTELLE MARIE</au><au>JEEVARATNAM REVATHY PERPETUA</au><au>WILLIAMS GEOFFREY MARTYN</au><au>SWAIN SIMON ANDREW</au><au>SMITH COLIN PETER SAMBROOK</au><au>RUSHWORTH PHILIP JOHN</au><au>FYFE MATTHEW COLIN THOR</au><au>BRADLEY STUART EDWARD</au><au>KEILY JOHN</au><au>PROCTER MARTIN JAMES</au><au>STONEHOUSE DAVID FRENCH</au><au>BERTRAM LISA SARAH</au><au>GATTRELL WILLIAM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GPCR-agonister</title><date>2008-01-30</date><risdate>2008</risdate><abstract>Forbindelser med formel (I): (I) eller farmasøytisk akseptable salter derav, er GPCR-agonister og er anvendelige når det gjelder behandlingen av fedme og diabetes.
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | nor |
| recordid | cdi_epo_espacenet_NO20080010LL |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | GPCR-agonister |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T13%3A38%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RASAMISON%20CHRYSTELLE%20MARIE&rft.date=2008-01-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENO20080010LL%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |